Please login to the form below

Not currently logged in
Email:
Password:

Ergomed appoints CEO of PrimeVigilance

Dr Jan Petracek to drive pharmacoviglance business

Jan_Petracek_ErgomedErgomed has appointed Dr Jan Petracek the new CEO of its pharmacoviglance business PrimeVigilance.

Dr Petracek was previously CEO of European PharmInvent Services, which Ergomed acquired in 2016 and subsequently integrated into PrimeVigilance, and prior to that he served at the likes of MediWound and Vertext Pharmaceuticals.

Dr Miroslav Reljanovic, CEO of Ergomed, said: “We are fortunate to have in the wings a replacement CEO of the calibre of Dr Jan Petracek.

“As founder of PharmInvent and former regulator at EMA, his unique combination of entrepreneurship and specialist pharmacoviglance expertise will serve to drive forward our pharmacoviglance businesses.”

Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition period.

26th April 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics